Immunogen, Inc. (IMGN) Posts Narrower than Expected Q2 Loss
IMGN Hot Sheet
Revenue Growth %: -37.5%Financial Fact:
General and administrative: 5.02M
Today's EPS Names:
TARO, BRLI, TLB, More
Immunogen, Inc. (NASDAQ: IMGN) reported Q2 EPS of ($0.17), $0.06 better than the analyst estimate of ($0.23). Revenue for the quarter came in at $7.6 million versus the consensus estimate of $5.43 million.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- UPDATE: Ralph Lauren Corp (RL) Reports Solid Q4 Results; Guides FY13 Sales
- UPDATE: NetApp, Inc. (NTAP) Tops Q4 EPS by 3c; Guides Q1 Lower
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
